ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

LSB LakeShore Biopharma Company Ltd

2.45
0.0398 (1.65%)
15 Feb 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2023Sep 2023
CNY (元)CNY (元)CNY (元)CNY (元)
Total Revenue 176.27M96.82M
Operating Income -70.05M-113.21M
Pre Tax Income -70.13M-105.22M
Net Income -69.54M-104.98M
Preferred Dividends 00
Basic Earnings Per Share (EPS) 00
EBIT -68.79M-100.43M
EBITDA -70.05M-93.27M
Year End 31 March 2024 2021202220232024
CNY (元)CNY (元)CNY (元)CNY (元)
Total Revenue 257.02M502.95M687.2M573.42M
Operating Income -125.85M-118.96M-139.38M-445.83M
Pre Tax Income -174.37M-101.07M-144.35M-455.19M
Net Income -208.44M-236.67M-283.47M-433.47M
Preferred Dividends -16.61M-130.66M00
Basic Earnings Per Share (EPS) -0.843-0.957-3.046-2.279
EBIT -144.68M-98.35M-113.51M-415.31M
EBITDA -97.94M-87.81M-102.69M-246.23M

Your Recent History

Delayed Upgrade Clock